REQUEST A DEMO
Total
USD $0.00
Search more companies

Ensol Biosciences Inc. (South Korea)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Ensol Biosciences Inc. Profile Updated: May 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ensol Biosciences Inc. is an enterprise located in South Korea, with the main office in Daejeon. It operates in the Biological Product (except Diagnostic) Manufacturing industry. The company was established on May 23, 2026. Ensol Biosciences Inc. currently employs 27 (2025) people. There was a net sales revenue drop of 98.25% reported in Ensol Biosciences Inc.’s latest financial highlights for 2025. Over the same period, its total assets grew by 319.07%. In 2025, Ensol Biosciences Inc.’s net profit margin decreased by 20059.09%.

Headquarters
51, Techno 10-Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Ensol Biosciences Inc. report to view the information.

Website: http://www.ensolbio.co.kr

Basic Information
Total Employees:
Purchase the Ensol Biosciences Inc. report to view the information.
Outstanding Shares:
Purchase the Ensol Biosciences Inc. report to view the information.
Financial Auditors:
Purchase the Ensol Biosciences Inc. report to view the information.
Incorporation Date:
May 23, 2026
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
(주)비손사이언스
100%
Company Performance
Financial values in the chart are available after Ensol Biosciences Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-98.25%
Total Operating Revenue
-95.73%
Operating Profit
-35.51%
EBITDA
-48.7%
Net Profit/Loss for the Period
69.91%
Total Assets
319.07%
Total Equity
N/A
Operating Profit Margin
-28199.45%
Net Profit Margin
-20059.09%
Return on Equity (ROE)
N/A
Debt / Equity
N/A
Quick Ratio
1.58%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?